Debt to Equity Ratio Chart

View Debt to Equity Ratio for BYSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.0048
March 31, 2026 -0.0071
December 31, 2025 -0.0099
September 30, 2025 -0.0128
June 30, 2025 -0.0158
March 31, 2025 -0.0193
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 0.134
September 30, 2021 0.093
June 30, 2021 0.0587
March 31, 2021 0.0461
Date Value
December 31, 2020 0.0488
September 30, 2020 0.181
June 30, 2020 0.1402
March 31, 2020 0.2256
December 31, 2019 0.13
September 30, 2019 0.1969
June 30, 2019 -0.4349
March 31, 2019 -0.4106
December 31, 2018 0.00
September 30, 2018
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0565
Alnylam Pharmaceuticals, Inc. 2.206
Anika Therapeutics, Inc. 0.1839
Savara, Inc. 0.2117
Vericel Corp. 0.2556